000 | 01632 a2200481 4500 | ||
---|---|---|---|
005 | 20250517032948.0 | ||
264 | 0 | _c20160621 | |
008 | 201606s 0 0 eng d | ||
022 | _a1530-0447 | ||
024 | 7 |
_a10.1038/pr.2015.96 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aStark, Michael J | |
245 | 0 | 0 |
_aEffects of antenatal magnesium sulfate treatment for neonatal neuro-protection on cerebral oxygen kinetics. _h[electronic resource] |
260 |
_bPediatric research _cSep 2015 |
||
300 |
_a310-4 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aBrain _xmetabolism |
650 | 0 | 4 |
_aBrain Injuries _xpathology |
650 | 0 | 4 |
_aCarotid Arteries _xpathology |
650 | 0 | 4 | _aCerebrovascular Circulation |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGestational Age |
650 | 0 | 4 | _aHemodynamics |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInfant, Newborn |
650 | 0 | 4 | _aInfant, Premature |
650 | 0 | 4 | _aInfant, Premature, Diseases |
650 | 0 | 4 | _aKinetics |
650 | 0 | 4 |
_aMagnesium Sulfate _xtherapeutic use |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMaternal Exposure |
650 | 0 | 4 |
_aNeuroprotective Agents _xtherapeutic use |
650 | 0 | 4 |
_aOxygen _xmetabolism |
650 | 0 | 4 | _aOxygen Consumption |
650 | 0 | 4 | _aPregnancy |
650 | 0 | 4 | _aPrenatal Care |
650 | 0 | 4 | _aSpectroscopy, Near-Infrared |
650 | 0 | 4 |
_aTocolytic Agents _xtherapeutic use |
700 | 1 | _aHodyl, Nicolette A | |
700 | 1 | _aAndersen, Chad C | |
773 | 0 |
_tPediatric research _gvol. 78 _gno. 3 _gp. 310-4 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/pr.2015.96 _zAvailable from publisher's website |
999 |
_c24911607 _d24911607 |